SN
Live price temporarily unavailable.
Price history
Syndax Pharmaceuticals Inc (SNDX) is a Health Care company in the Russell 2000. Latest news and coverage below.
IPO: March 3, 2016 · $12.00 offering · NASDAQ · View IPO details →
Recent News (3)
-
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) NEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on Septem…
-
UBS lowers Syndax Pharmaceuticals price target on revenue outlook
UBS lowers Syndax Pharmaceuticals price target on revenue outlook
-
Syndax Pharmaceuticals stock price target lowered to $26 by BofA
Syndax Pharmaceuticals stock price target lowered to $26 by BofA
More Health Care stocks
- AZN AstraZeneca
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- AMGN Amgen
- BAX Baxter International